Diabetes Core Update cover image

Diabetes Core Update – April 2024

Diabetes Core Update

00:00

Cardiovascular and Kidney Risks in Type 2 Diabetes: Addressing Adiposity

The chapter explores the impact of excess adiposity on cardiovascular and kidney risks in individuals with type two diabetes, emphasizing findings from studies such as the Select trial and the 2B published flow trial. It discusses the favorable effects of SGLT2 inhibitors on heart failure outcomes and the importance of addressing weight-related risks early in disease progression. The conversation also touches on Medicare funding weight loss programs for individuals with atherosclerosis and the evolving role of therapeutics in managing cardiometabolic issues.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app